Marlies Götz

Diakonie-Klinikum Stuttgart — Germany

Biochemistry, Genetics and Molecular Biology · Life Sciences

17h-index1.0kcitations66works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(20), Retinoids in leukemia and cellular processes(19), Acute Myeloid Leukemia Research(15), interferon and immune responses(14), Hematopoietic Stem Cell Transplantation(11)

Publications66 total

Immunotherapeutic Potential of Mutated NPM1 for the Treatment of AML
Preprints.org·2024· 3 citedOpen Access
A Combination of the Immunotherapeutic Drug Anti-Programmed Death 1 with Lenalidomide Enhances Specific T Cell Immune Responses against Acute Myeloid Leukemia Cells
International Journal of Molecular Sciences·2023· 8 citedOpen Access
The effect of the immune checkpoint inhibitor anti-LAG-3 on antigen-specific T-cells compared with nivolumab in vitro in head and neck cancer
Laryngo-Rhino-Otologie·2023
Die Wirkung des Immuncheckpoint-Inhibitors anti-LAG-3 auf antigenspezifische T-Zellen im Vergleich zu Nivolumab in vitro bei Kopf-Hals-Karzinomen
Laryngo-Rhino-Otologie·2023
Supplementary Table 6 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 6 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 7 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Data from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 2 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 3 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 2 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Figures 1 - 2 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 1 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Figures 1 - 2 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Tables 4 - 5 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 7 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 8 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 3 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Supplementary Table 8 from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
Data from PRAME-Induced Inhibition of Retinoic Acid Receptor Signaling-Mediated Differentiation—A Possible Target for ATRA Response in AML without t(15;17)
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Jochen Greiner(32), Susanne Hofmann(29), Hartmut Döhner(28), Vanessa Schneider(20), Markus Wiesneth(16), Michael Schmitt(15), Donald Bunjes(15), Lars Bullinger(13), Konstanze Döhner(12), Hubert Schrezenmeier(12), Anita Schmitt(10), Richard F. Schlenk(8), Ursula Botzenhardt(8), Anna Babiak(8), Markus Rojewski(7), Annika C. Russ(7), Lu Zhang(7), Philippe Guillaume(6), Michael Henry Schmitt(6), J. Greiner(6)